Delivery Order SPE2DB20D3505-SPE2DB25FYCDB
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Abiroterone Acetate 250 mg tablets (120-count supply) on September 15, 2025, with a ceiling value of $1,539.02. This competitive, firm fixed-price delivery order is scheduled for ultimate completion by September 16, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order valued at $10,774.15 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120 count) on July 21, 2025, with completion scheduled for July 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $37,489.04 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120-count units) under a firm fixed-price contract. This non-competitive delivery order, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a pharmaceutical procurement supporting federal medical supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major...
- The Defense Logistics Agency awarded a delivery order valued at $31,517.29 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 500 mg tablets (60-count units). This competitive, firm fixed-price contract was awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count) valued at $13,701.92. This firm fixed-price delivery order is classified as non-competitive and will be completed by July 22, 2025. The product will be delivered to AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $1,340.06 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 500 mg tablets (60 count) on August 13, 2025, with completion targeted for August 14, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and represents a child delivery order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX). The pharmaceutical products will be...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count packages) with a ceiling value of $184,749.89. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $8,006.80. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs across military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60 count) with a ceiling value of $13,456.36. This is a firm fixed price delivery order with no set-aside designation, completed competitively, with a performance location in Conshohocken, Pennsylvania and an ultimate completion date of September 10, 2025. The award represents a single delivery order issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $13,023.83 on July 28, 2025, for the supply of Abiroterone Acetate 500 mg tablets (60-count units). This is a firm fixed-price, non-set-aside contract with performance completion targeted for July 29, 2025, and fulfillment occurring at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Abiroterone Acetate is a hormone therapy medication commonly used in cancer treatment, reflecting the Defense...
- SPE2DB20D3505Indefinite Delivery Contract
- SPE2DB20D3505-SPE2DB25FYCDBDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count units) with a ceiling value of $9,372.25. This non-compete, firm fixed-price delivery order is scheduled for completion by September 4, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply services under AmerisourceBergen's existing contract vehicles with the DLA. This delivery order falls under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.9 million through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen leverages this prime contract to supply a wide spectrum of medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The present award demonstrates the contractor's continued role in fulfilling critical pharmaceutical procurement needs for defense medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 9/3/25 |